❌ Error!

News item not found

📰 Psychedelics News

Curated updates on microdosing, research, policy, and community.

Filters

2026-03-15 The Psychedelic Blog (Substack)

The Moment I Realized My Life Was Pre-Written

This week’s Sunday Insider: The morning after a Psychedelic journey, I became convinced my life had been written before I ever lived it.

2026-03-14 Chemical Collective

Opening the Heart with San Pedro

Oli Genn-Bash describes his first San Pedro cactus ceremony in Cusco, Peru, as a gentle yet transformative psychedelic experience that, despite its subtlety, facilitated deep emotional release and long-lasting insight...

2026-03-13 The Microdose (Berkeley)

Psilocybin seems to help tobacco smokers quit; Scientists discover a new species of psychedelic mushroom in Africa

Plus: Minnesota lawmakers advance psilocybin-assisted therapy bill and Mississippi lawmakers approve ibogaine research bill; Psychedelics with exercise to treat major depressive disorder?

2026-03-13 The Psychedelic Blog (Substack)

Life Gives You a Menu. Psychedelics Make You Ask Who Wrote It.

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

2026-03-13 DoubleBlind Magazine

Inside a Johns Hopkins Study Giving Psilocybin to Lyme Patients

Here's what researchers found after chronic Lyme patients received two doses of psilocybin. [...] Read More... The post Inside a Johns Hopkins Study Giving Psilocybin to Lyme Patients appeared first on DoubleBlind Mag.

2026-03-12 Breaking Convention (Substack)

Earlybird tickets nearly sold out!

Plus new speakers announced and other events!

2026-03-12 Chemical Collective

Marcuse on Psychedelics and Revolutionary Consciousness

Herbert Marcuse argued that Western capitalism has conditioned people to desire consumerist “false needs” and proposed a radical “Great Refusal” and shift in consciousness – potentially aided by psychedelics – as a pa...

2026-03-11 Psychedelic Alpha

Pα+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley Says R-MDMA Met Safety Goal in SAD, Details Phase 3 Design for 5-MeO-DMT in TRD; Psilocybin for Smoking Cessation Study Published

Policy Round-Up: State Momentum, Congressional Signals, and Colorado’s Data Build-Out • RAND Survey: Americans Divided on Psilocybin Legalisation • Helus’ Phase 2a Study of Intravenous DMT in MDD Published in Nat...

2026-03-11 MAPS

MAPS, in Partnership with the Shulgin Foundation, Launches Music Is the Bridge Video Series; First Episode Features Reggie Watts and Hamilton Morris

Lafayette, CA (March, XX, 2026) — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit advancing research, education, and advocacy around psychedelics and cannabis, announced a colla...

2026-03-11 DoubleBlind Magazine

Where in the World Is Psychedelic Therapy Legal?

A look at where psychedelic-assisted therapy is actually legal around the world. [...] Read More... The post Where in the World Is Psychedelic Therapy Legal? appeared first on DoubleBlind Mag.

2026-03-10 Chemical Collective

Book Review: Psilocybe Pickers by Rob Dickins

The story of British magic mushroom picking culture has been left largely undocumented, with folklore and myths surrounding its spread across the country. In Psilocybe Pickers: A Short History Of Bemushroomed Britons,...

2026-03-09 MAPS

MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs

Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior academics, advocates, Veterans, and policy experts to the 69th session of the United Nations Commission...

Policy
2026-03-09 Psychedelics Today

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots

HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including for veterans. One provision stands out: a requirement that participating organizations create benefit...

2026-03-09 The Microdose (Berkeley)

Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein

Eisenkraft Klein discusses the FDA’s new accelerated drug review program.

2026-03-09 Psychedelics Today

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

Jen Davenport joins Psychedelics Today to interview the CEO and co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psyche...